Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00081744
Status:
COMPLETED
Last Update Posted:
2013-02-08
First Post:
2004-04-19
Brief Title:
Study Comparing Tigecycline to ImipenemCilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Multicenter Double-Blind Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None